13F Data
13F filer · CIK 1858703

Blue Owl Capital Holdings LP

New York, NY · filing since Q4 2021 · last filing Aug 11, 2026
Reported value
$664.5M
+$292.3M vs prior
Positions
76
New / sold out
23 / 22
Added / reduced
11 / 13
Turnover
18.0%
buys $339.9M · sells $93.1M
Top-10 weight
78.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewSPACE EXPLORATION TECHN CORP+1,398,815–+$239.0M
NewCAPITAL ONE FINL CORP+119,757–+$24.0M
NewDEEP FISSION INC+1,333,333–+$14.7M
NewARTIVA BIOTHERAPEUTICS INC+874,542–+$8.5M
AddedDELL TECHNOLOGIES INC+19,062+137.1%+$8.2M
AddedSAGIMET BIOSCIENCES INC+926,667+277.5%+$7.2M
NewCOMPASS PATHWAYS PLC+450,000–+$6.4M
AddedLARIMAR THERAPEUTICS INC+2,043,150+28.7%+$6.2M
NewCOMPASS PATHWAYS PLCCALL+1,670,500–+$5.2M
NewVIRIDIAN THERAPEUTICS INC+260,000–+$4.8M
24 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outENGENE HOLDINGS INC-4,416,353-100.0%$-30.1M
ReducedMAPLIGHT THERAPEUTICS INC-276,000-27.4%$-9.9M
ReducedCULLINAN THERAPEUTICS INC-370,000-19.4%$-6.7M
Sold outCOMPASS PATHWAYS PLC-1,804,504-100.0%$-5.1M
Sold outCIVEO CORP CDA-180,475-100.0%$-4.8M
Sold outKALVISTA PHARMACEUTICALS INC-215,000-100.0%$-4.3M
Sold outOVID THERAPEUTICS INC-1,904,666-100.0%$-4.2M
ReducedULTRAGENYX PHARMACEUTICAL IN-120,000-39.7%$-4.0M
Sold outPLIANT THERAPEUTICS INC-2,969,199-100.0%$-3.7M
ReducedELEDON PHARMACEUTICALS INC-853,403-60.1%$-3.4M
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $301.2MQ1 2022: $227.2MQ2 2022: $203.6MQ3 2022: $230.9MQ4 2022: $235.0MQ1 2023: $156.1MQ2 2023: $162.3MQ3 2023: $129.3MQ4 2023: $418.3MQ1 2024: $500.6MQ2 2024: $359.6MQ3 2024: $518.4MQ4 2024: $434.0MQ1 2025: $310.1MQ2 2025: $309.9MQ3 2025: $322.1MQ4 2025: $324.0MQ1 2026: $372.2MQ2 2026: $664.5M
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SPACE EXPLORATION TECHN CORPCLASS A COM STK1,398,815$239.0M35.97%
2AKTIS ONCOLOGY INCCOM3,070,219$99.0M14.89%
3CULLINAN THERAPEUTICS INCCOM1,539,764$28.0M4.22%
4LARIMAR THERAPEUTICS INCCOM9,163,157$27.9M4.21%
5NUVEEN CHURCHILL DIRECT LENDCOM SHS2,143,626$26.6M4.01%
6MAPLIGHT THERAPEUTICS INCCOM729,929$26.2M3.94%
7CAPITAL ONE FINL CORPCOM119,757$24.0M3.62%
8BLUE OWL CAPITAL CORPORATIONCOM2,045,070$22.2M3.35%
9DEEP FISSION INCCOM1,333,333$14.7M2.22%
10DELL TECHNOLOGIES INCCL C32,961$14.2M2.14%
66 more rows. Subscribe for $29/month to see every row, download the data and use the API.